Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.

Ruijgrok EJ, Fens MH, Bakker-Woudenberg IA, van Etten EW, Vulto AG.

Antimicrob Agents Chemother. 2006 May;50(5):1852-4.

2.
5.
6.

Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats.

Van Etten EW, Stearne-Cullen LE, ten Kate M, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 2000 Mar;44(3):540-5.

8.

Superior efficacy of liposomal amphotericin B with prolonged circulation in blood in the treatment of severe candidiasis in leukopenic mice.

van Etten EW, Snijders SV, van Vianen W, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 1998 Sep;42(9):2431-3.

9.

Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system.

van Etten EW, ten Kate MT, Snijders SV, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 1998 Jul;42(7):1677-81.

10.

PCR monitoring of response to liposomal amphotericin B treatment of systemic candidiasis in neutropenic mice.

van Deventer AJ, Goessens WH, van Belkum A, van Etten EW, van Vliet HJ, Verbrugh HA.

J Clin Microbiol. 1996 Jan;34(1):25-8.

11.

Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans.

van Etten EW, Chander HR, Snijders SV, Bakker-Woudenberg IA.

J Antimicrob Chemother. 1995 Dec;36(6):961-74.

PMID:
8821595
12.
13.

Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.

van Etten EW, Otte-Lambillion M, van Vianen W, ten Kate MT, Bakker-Woudenberg AJ.

J Antimicrob Chemother. 1995 Apr;35(4):509-19.

PMID:
7628985
14.

Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis.

van Deventer AJ, Goessens WH, van Belkum A, van Vliet HJ, van Etten EW, Verbrugh HA.

J Clin Microbiol. 1995 Mar;33(3):625-8.

15.

Liposomes as delivery systems in the prevention and treatment of infectious diseases.

Bergers JJ, ten Hagen TL, van Etten EW, Bakker-Woudenberg IA.

Pharm World Sci. 1995 Jan 27;17(1):1-11. Review.

PMID:
7719272
16.
17.

Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections.

Bakker-Woudenberg IA, Lokerse AF, ten Kate MT, Melissen PM, van Vianen W, van Etten EW.

Eur J Clin Microbiol Infect Dis. 1993;12 Suppl 1:S61-7. Review.

PMID:
8477767
18.

Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.

van Etten EW, van de Rhee NE, van Kampen KM, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 1991 Nov;35(11):2275-81.

19.

Flight-induced inhibition of the cerebral median peptidergic neurosecretory system in Locusta migratoria.

Diederen JH, van Etten EW, Biegstraaten AI, Terlou M, Vullings HG, Jansen WF.

Gen Comp Endocrinol. 1988 Aug;71(2):257-64.

PMID:
3203873

Supplemental Content

Loading ...
Support Center